Immunocytochemical Detection of the Androgen Receptor In Fine Needle Aspirates From Benign and Malignant Human Prostate

A monoclonal antibody to the androgen receptor was applied to fine needle aspirates from patients with benign and malignant prostatic disease. the series includes six patients with benign hyperplasia and 24 patients with prostatic carcinomas. the androgen receptor was detected in most nuclei of both benign and malignant epithelial cells. the intensity of immunostaining varied. No obvious relation was observed between the intensity of the staining in benign versus malignant cells. In addition no clear differences were found in the proportion of androgen receptor positive cells in benign aspirates as compared with aspirates from well differentiated or moderately well differentiated prostatic carcinomas. the relative number of androgen receptor positive cells was highest in smears from poorly differentiated prostatic carcinomas.